Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction

医学 心脏病学 内科学 心肌梗塞 心力衰竭 射血分数 入射(几何) 心肌梗死并发症 心肌梗死的心电图 随机对照试验 冲程容积 心脏病 心源性休克
作者
Anna Meta Dyrvig Kristensen,Xavier Rosselló,Dan Atar,Troels Yndigegn,Takeshi Kimura,Roberto Latini,Bertil Lindahl,Sigrun Halvorsen,Michael Hecht Olsen,Valentín Fuster,Robin Hofmann,Kjell Vikenes,Michael Mæng,David Erlinge,Stuart Pocock,Patric Karlström,Arnhild Bakken,Theis Lange,José A. Barrabés,Jocelyne R Benatar
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
卷期号:394 (6): 540-550 被引量:92
标识
DOI:10.1056/nejmoa2512686
摘要

BACKGROUND: The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction (LVEF) is unclear. METHODS: We conducted a meta-analysis at the individual-patient level using data from five open-label trials that randomly assigned patients with recent myocardial infarction, no other indications for beta-blocker therapy, and an LVEF of at least 50% to receive beta-blocker therapy or no beta-blocker therapy. The primary end point was a composite of death from any cause, myocardial infarction, or heart failure. Event rates were analyzed with a one-stage fixed-effects Cox proportional-hazards model. RESULTS: A total of 17,801 patients were included from the REBOOT (7459 patients), REDUCE-AMI (4967 patients), BETAMI (2441 patients), DANBLOCK (2277 patients), and CAPITAL-RCT (657 patients) trials. Of these 17,801 patients, 8831 (49.6%) were assigned to receive a beta-blocker and 8970 (50.4%) were assigned to receive no beta-blocker. During a median follow-up of 3.6 years (interquartile range, 2.3 to 4.6), a primary-end-point event occurred in 717 patients (8.1%) in the beta-blocker group and 748 patients (8.3%) in the no-beta-blocker group (hazard ratio, 0.97; 95% confidence interval [CI], 0.87 to 1.07; P = 0.54). Death from any cause occurred in 335 patients in the beta-blocker group and 326 patients in the no-beta-blocker group (hazard ratio, 1.04; 95% CI, 0.89 to 1.21); myocardial infarction occurred in 360 and 407 patients, respectively (hazard ratio, 0.89; 95% CI, 0.77 to 1.03); and heart failure occurred in 75 and 87 patients (hazard ratio, 0.87; 95% CI, 0.64 to 1.19). CONCLUSIONS: In this meta-analysis including individual-patient data from five randomized trials, beta-blocker therapy did not reduce the incidence of death from any cause, myocardial infarction, or heart failure in patients with an LVEF of at least 50% after myocardial infarction without other indications for beta-blockers. (Funded by Centro Nacional de Investigaciones Cardiovasculares Carlos III and others; PROSPERO database number, CRD420251119176.).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
华仔的应助被花样年华采纳,获得10
1秒前
JamesPei的应助被dbyte采纳,获得10
2秒前
Owen的应助被dbyte采纳,获得10
2秒前
周政完成签到,获得积分10
2秒前
Jasper的应助被dbyte采纳,获得10
2秒前
panda发布了新的文献求助10
2秒前
2秒前
3秒前
乎乎发布了新的文献求助10
3秒前
3秒前
zhang0403发布了新的文献求助10
4秒前
4秒前
4秒前
5秒前
chunxiuxie完成签到,获得积分10
5秒前
猫的理想完成签到 ,获得积分10
5秒前
5秒前
5秒前
李健的小迷弟的应助被古尔雅采纳,获得10
6秒前
Orange的应助被好吗好的采纳,获得10
6秒前
十七发布了新的文献求助10
7秒前
隐形曼青的应助被serein采纳,获得10
7秒前
7秒前
忧心的曼凝的应助被12138采纳,获得10
7秒前
Lucas的应助被曾经高跟鞋采纳,获得10
8秒前
李健的应助被fff采纳,获得10
9秒前
10秒前
10秒前
10秒前
钟梓袄发布了新的文献求助10
11秒前
Feng的应助被学术怪咖采纳,获得20
11秒前
Vista2023toFD完成签到,获得积分10
11秒前
Jasper的应助被自由草莓采纳,获得10
11秒前
11秒前
琳琳林完成签到,获得积分20
11秒前
11秒前
华仔的应助被AnnChen采纳,获得10
12秒前
小马甲的应助被花样年华采纳,获得150
12秒前
852的应助被热爱科研的小孩采纳,获得10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572434
关于积分的说明 21825655
捐赠科研通 7779988
什么是DOI,文献DOI怎么找? 3433852
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480148